跳至主要内容
临床试验/NCT01852734
NCT01852734已完成不适用

Uterine Fibroid Embolization- Long Term Follow up and Technical Perspectives

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2013年11月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
52
试验地点
2
主要终点
clinical effect

研究概览

简要总结

The purpose of this prospective non-randomised study is to examine whether two different microspheres (Bead-Block and Embosphere) are equally effective in the treatment of the uterine fibroid controlled with contrast-enhanced MR examination.

Quantitative MR imaging, including dominant fibroid T1, T2 and contrast enhancement characteristics before intervention and 3 months after interventions will be analysed as a potential predictor of volumetric response after embolization.

Another purpose is to determine long-term follow-up in all patient treated in a period from 2001-2011 in OUH analysed retrospectively.

详细描述

Group 1: 26 patient will be treated with Bead-block microspheres - 700-900 µm microspheres or combinations of one vial 2 ml of 500-700 µm microspheres, follow by 700-900 µm microspheres until blood flow stop ( " cut the tree" appearance).

Group 2: 26 patient will be treated with Embosphere; 500-900 µm until "near-stasis" flow stop in the uterine artery.

Clinical and Technical success will be examined, and radiological follow-up 3 and 12 months after embolization using MR contrast-enhanced examination in a Bead Block group and only 3 months control in Embosphere group to assess total fibroid burden infraction degree and eventually residual contracts fibroid enhancement.

Quantitative MRI dominant fibroid characteristic for and 3 months after an intervention to examine eventually potential of as a possible predictor of the volumetric response of the uterine fibroid.

Retrospective study compromised all patient treated between January 2001 until January 2011 with follow up to January 2014, and re-intervention as well as complications rate analysis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 52 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • symptomatic uterus fibroma

排除标准

  • pelvic infection (cystitis, oophoritis, salpingitis, abscess, urethritis)
  • gravidity
  • uterus malignancy
  • big subserosal fibroma with stalk diameter of <2 cm
  • menopausal women
  • don,t want to be included into the study
  • concomitant adenomyosis

结局指标

主要结局

clinical effect

时间窗: one year

Primary goal is to achieve release of symptoms after intervention and it would be compared between the two techniques

次要结局

  • reinterventions rate(one year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Stevo Duvnjak,MD

Medical Doctor, Radiologist

Odense University Hospital

研究点 (2)

Loading locations...

相似试验